By 2028, the landscape of neonatal care will be dramatically transformed by revolutionary developments. High-risk infants will benefit from customized treatment plans enabled by state-of-the-art diagnostics tools. Artificial intelligence will play a pivotal role in analyzing potential health concerns, allowing for timely treatment. The convergence